Delivering amoxicillin at the infection site – a rational design through lipid nanoparticles
Daniela Lopes-de-Campos,1,* Rita M Pinto,1,* Sofia A Costa Lima,1 Tiago Santos,2,3 Bruno Sarmento,2–4 Cláudia Nunes,1 Salette Reis1 1LAQV, REQUIMTE, Departamento de Ciáncias Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cbd1982c3b1546a387318fbc096f3ccd |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:cbd1982c3b1546a387318fbc096f3ccd |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:cbd1982c3b1546a387318fbc096f3ccd2021-12-02T03:57:26ZDelivering amoxicillin at the infection site – a rational design through lipid nanoparticles1178-2013https://doaj.org/article/cbd1982c3b1546a387318fbc096f3ccd2019-04-01T00:00:00Zhttps://www.dovepress.com/delivering-amoxicillin-at-the-infection-site-a-rational-design-through-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Daniela Lopes-de-Campos,1,* Rita M Pinto,1,* Sofia A Costa Lima,1 Tiago Santos,2,3 Bruno Sarmento,2–4 Cláudia Nunes,1 Salette Reis1 1LAQV, REQUIMTE, Departamento de Ciáncias Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; 2INEB – Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal; 3i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; 4IINFACTS, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Instituto Universitário de Ciências da Saúde, Gandra, Portugal *These authors contributed equally to this work Purpose: Amoxicillin is a commonly used antibiotic, although degraded by the acidic pH of the stomach. This is an important limitation for the treatment of Helicobacter pylori infections. The purpose of this work was to encapsulate amoxicillin in lipid nanoparticles, increasing the retention time at the site of infection (gastric mucosa), while protecting the drug from the harsh conditions of the stomach lumen.Materials and methods: The nanoparticles were produced by the double emulsion technique and optimized by a three-level Box-Behnken design. Tween 80 and linolenic acid were used as potential therapeutic adjuvants and dioleoylphosphatidylethanolamine as a targeting agent to Helicobacter pylori. Nanoparticles were characterized regarding their physico-chemical features, their storage stability, and their usability for oral administration (assessment of in vitro release, in vitro cell viability, permeability, and interaction with mucins).Results: The nanoparticles were stable for at least 6 months at 4°C. In vitro release studies revealed a high resistance to harsh conditions, including acidic pH and physiologic temperature. The nanoparticles have a low cytotoxicity effect in both fibroblasts and gastric cell lines, and they have the potential to be retained at the gastric mucosa.Conclusion: Overall, the designed formulations present suitable physico-chemical features for being henceforward used by oral administration to treat Helicobacter pylori infections. Keywords: linolenic acid, dioleoylphosphatidylethanolamine, Box-Behnken design, permeability, mucins, Helicobacter pyloriLopes-de-Campos DPinto RMCosta Lima SASantos TSarmento BNunes CReis SDove Medical Pressarticlelinolenic aciddioleoylphosphatidylethanolamineBox-Behnken designpermeabilitymucinsHelicobacter pyloriMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 2781-2795 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
linolenic acid dioleoylphosphatidylethanolamine Box-Behnken design permeability mucins Helicobacter pylori Medicine (General) R5-920 |
| spellingShingle |
linolenic acid dioleoylphosphatidylethanolamine Box-Behnken design permeability mucins Helicobacter pylori Medicine (General) R5-920 Lopes-de-Campos D Pinto RM Costa Lima SA Santos T Sarmento B Nunes C Reis S Delivering amoxicillin at the infection site – a rational design through lipid nanoparticles |
| description |
Daniela Lopes-de-Campos,1,* Rita M Pinto,1,* Sofia A Costa Lima,1 Tiago Santos,2,3 Bruno Sarmento,2–4 Cláudia Nunes,1 Salette Reis1 1LAQV, REQUIMTE, Departamento de Ciáncias Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; 2INEB – Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal; 3i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; 4IINFACTS, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Instituto Universitário de Ciências da Saúde, Gandra, Portugal *These authors contributed equally to this work Purpose: Amoxicillin is a commonly used antibiotic, although degraded by the acidic pH of the stomach. This is an important limitation for the treatment of Helicobacter pylori infections. The purpose of this work was to encapsulate amoxicillin in lipid nanoparticles, increasing the retention time at the site of infection (gastric mucosa), while protecting the drug from the harsh conditions of the stomach lumen.Materials and methods: The nanoparticles were produced by the double emulsion technique and optimized by a three-level Box-Behnken design. Tween 80 and linolenic acid were used as potential therapeutic adjuvants and dioleoylphosphatidylethanolamine as a targeting agent to Helicobacter pylori. Nanoparticles were characterized regarding their physico-chemical features, their storage stability, and their usability for oral administration (assessment of in vitro release, in vitro cell viability, permeability, and interaction with mucins).Results: The nanoparticles were stable for at least 6 months at 4°C. In vitro release studies revealed a high resistance to harsh conditions, including acidic pH and physiologic temperature. The nanoparticles have a low cytotoxicity effect in both fibroblasts and gastric cell lines, and they have the potential to be retained at the gastric mucosa.Conclusion: Overall, the designed formulations present suitable physico-chemical features for being henceforward used by oral administration to treat Helicobacter pylori infections. Keywords: linolenic acid, dioleoylphosphatidylethanolamine, Box-Behnken design, permeability, mucins, Helicobacter pylori |
| format |
article |
| author |
Lopes-de-Campos D Pinto RM Costa Lima SA Santos T Sarmento B Nunes C Reis S |
| author_facet |
Lopes-de-Campos D Pinto RM Costa Lima SA Santos T Sarmento B Nunes C Reis S |
| author_sort |
Lopes-de-Campos D |
| title |
Delivering amoxicillin at the infection site – a rational design through lipid nanoparticles |
| title_short |
Delivering amoxicillin at the infection site – a rational design through lipid nanoparticles |
| title_full |
Delivering amoxicillin at the infection site – a rational design through lipid nanoparticles |
| title_fullStr |
Delivering amoxicillin at the infection site – a rational design through lipid nanoparticles |
| title_full_unstemmed |
Delivering amoxicillin at the infection site – a rational design through lipid nanoparticles |
| title_sort |
delivering amoxicillin at the infection site – a rational design through lipid nanoparticles |
| publisher |
Dove Medical Press |
| publishDate |
2019 |
| url |
https://doaj.org/article/cbd1982c3b1546a387318fbc096f3ccd |
| work_keys_str_mv |
AT lopesdecamposd deliveringamoxicillinattheinfectionsitendasharationaldesignthroughlipidnanoparticles AT pintorm deliveringamoxicillinattheinfectionsitendasharationaldesignthroughlipidnanoparticles AT costalimasa deliveringamoxicillinattheinfectionsitendasharationaldesignthroughlipidnanoparticles AT santost deliveringamoxicillinattheinfectionsitendasharationaldesignthroughlipidnanoparticles AT sarmentob deliveringamoxicillinattheinfectionsitendasharationaldesignthroughlipidnanoparticles AT nunesc deliveringamoxicillinattheinfectionsitendasharationaldesignthroughlipidnanoparticles AT reiss deliveringamoxicillinattheinfectionsitendasharationaldesignthroughlipidnanoparticles |
| _version_ |
1718401581270958080 |